SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemours Co – ‘10-Q’ for 3/31/18 – ‘EX-31.1’

On:  Friday, 5/4/18, at 4:10pm ET   ·   For:  3/31/18   ·   Accession #:  1564590-18-10990   ·   File #:  1-36794

Previous ‘10-Q’:  ‘10-Q’ on 11/3/17 for 9/30/17   ·   Next:  ‘10-Q’ on 8/3/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/04/18  Chemours Co                       10-Q        3/31/18  116:18M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report -- cc-10q_20180331                 HTML   1.02M 
 2: EX-10.2     Material Contract                                   HTML     55K 
 3: EX-10.3     Material Contract                                   HTML     62K 
 8: EX-95       Mine-Safety Disclosure                              HTML     40K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
15: R1          Document and Entity Information                     HTML     52K 
16: R2          Interim Consolidated Statements of Operations       HTML     84K 
                (Unaudited)                                                      
17: R3          Interim Consolidated Statements of Comprehensive    HTML    118K 
                Income (Loss) (Unaudited)                                        
18: R4          Interim Consolidated Balance Sheets                 HTML    120K 
19: R5          Interim Consolidated Balance Sheets                 HTML     43K 
                (Parenthetical)                                                  
20: R6          Interim Consolidated Statements of Stockholders'    HTML     75K 
                Equity (Unaudited)                                               
21: R7          Interim Consolidated Statements of Cash Flows       HTML    109K 
                (Unaudited)                                                      
22: R8          Background, Description of the Business and Basis   HTML     39K 
                of Presentation                                                  
23: R9          Recent Accounting Pronouncements                    HTML    222K 
24: R10         Significant Transactions and Events                 HTML     35K 
25: R11         Net Sales                                           HTML    170K 
26: R12         Restructuring, Asset-Related, and Other Charges,    HTML    138K 
                Net                                                              
27: R13         Other Income, Net                                   HTML     63K 
28: R14         Income Taxes                                        HTML     39K 
29: R15         Earnings Per Share of Common Stock                  HTML     78K 
30: R16         Accounts and Notes Receivable, Net                  HTML     57K 
31: R17         Inventories                                         HTML     59K 
32: R18         Property, Plant, and Equipment, Net                 HTML     66K 
33: R19         Other Assets                                        HTML     56K 
34: R20         Accounts Payable                                    HTML     53K 
35: R21         Other Accrued Liabilities                           HTML     73K 
36: R22         Debt                                                HTML     94K 
37: R23         Other Liabilities                                   HTML     64K 
38: R24         Commitments and Contingent Liabilities              HTML     71K 
39: R25         Equity                                              HTML     37K 
40: R26         Financial Instruments                               HTML     78K 
41: R27         Long-term Employee Benefits                         HTML     75K 
42: R28         Stock-based Compensation                            HTML     56K 
43: R29         Segment Information                                 HTML    162K 
44: R30         Subsequent Events                                   HTML     48K 
45: R31         Guarantor Condensed Consolidating Financial         HTML   1.17M 
                Information                                                      
46: R32         Recent Accounting Pronouncements (Policies)         HTML    222K 
47: R33         Recent Accounting Pronouncements (Tables)           HTML    206K 
48: R34         Net Sales (Tables)                                  HTML    150K 
49: R35         Restructuring, Asset-Related, and Other Charges,    HTML    131K 
                Net (Tables)                                                     
50: R36         Other Income, Net (Tables)                          HTML     62K 
51: R37         Earnings Per Share of Common Stock (Tables)         HTML     81K 
52: R38         Accounts and Notes Receivable, Net (Tables)         HTML     53K 
53: R39         Inventories (Tables)                                HTML     59K 
54: R40         Property, Plant, and Equipment, Net (Tables)        HTML     65K 
55: R41         Other Assets (Tables)                               HTML     56K 
56: R42         Accounts Payable (Tables)                           HTML     52K 
57: R43         Other Accrued Liabilities (Tables)                  HTML     73K 
58: R44         Debt (Tables)                                       HTML     92K 
59: R45         Other Liabilities (Tables)                          HTML     63K 
60: R46         Financial Instruments (Tables)                      HTML    108K 
61: R47         Long-term Employee Benefits (Tables)                HTML     74K 
62: R48         Stock-based Compensation (Tables)                   HTML     46K 
63: R49         Segment Information (Tables)                        HTML    158K 
64: R50         Guarantor Condensed Consolidating Financial         HTML   1.16M 
                Information (Tables)                                             
65: R51         Background, Description of the Business and Basis   HTML     33K 
                of Presentation (Narrative) (Details)                            
66: R52         Recent Accounting Pronouncements (Narrative)        HTML     39K 
                (Details)                                                        
67: R53         Recent Accounting Pronouncements (Impacts of        HTML     85K 
                Adoption of Topic 606 on Consolidated Statements                 
                of Operations) (Details)                                         
68: R54         Recent Accounting Pronouncements (Reclassification  HTML     85K 
                of Non-operating Pension and Other Post-retirement               
                Employee Benefit Income) (Details)                               
69: R55         Significant Transactions and Events (Narrative)     HTML     43K 
                (Details)                                                        
70: R56         Net Sales (Narrative) (Details)                     HTML     52K 
71: R57         Net Sales - Summary of Disaggregation of Net Sales  HTML     80K 
                by Geographical Region, Product Group, and Segment               
                (Details)                                                        
72: R58         Net Sales - Summary of Contract Balances from       HTML     39K 
                Contracts with Customers (Details)                               
73: R59         Net Sales - Summary of Contract Balances from       HTML     41K 
                Contracts with Customers (Parenthetical) (Details)               
74: R60         Restructuring, Asset-Related, and Other Charges,    HTML     39K 
                Net (Charges) (Details)                                          
75: R61         Restructuring, Asset-Related, and Other Charges,    HTML     47K 
                Net (Segment Earnings) (Details)                                 
76: R62         Restructuring, Asset-Related, and Other Charges,    HTML     89K 
                Net (Narrative) (Details)                                        
77: R63         Restructuring, Asset-Related, and Other Charges,    HTML     55K 
                Net (Restructuring Program Schedule) (Details)                   
78: R64         Other Income,Net (Components of Other Income)       HTML     43K 
                (Details)                                                        
79: R65         Other Income,Net (Components of Other Income)       HTML     41K 
                (Parenthetical) (Details)                                        
80: R66         Income Taxes (Narrative) (Details)                  HTML     47K 
81: R67         Earnings Per Share of Common Stock (Earnings per    HTML     52K 
                Share Calculation) (Details)                                     
82: R68         Earnings Per Share of Common Stock (Anti-dilutive   HTML     34K 
                Shares Excluded from Computation of Earnings per                 
                Share) (Details)                                                 
83: R69         Accounts and Notes Receivable, Net (Schedule of     HTML     43K 
                Accounts and Notes Receivable) (Details)                         
84: R70         Accounts and Notes Receivable, Net (Schedule of     HTML     40K 
                Accounts and Notes Receivable) (Parenthetical)                   
                (Details)                                                        
85: R71         Accounts and Notes Receivable, Net (Narrative)      HTML     35K 
                (Details)                                                        
86: R72         Inventories (Details)                               HTML     49K 
87: R73         Property, Plant, and Equipment, Net (Details)       HTML     52K 
88: R74         Property, Plant, and Equipment, Net (Narrative)     HTML     38K 
                (Details)                                                        
89: R75         Other Assets (Details)                              HTML     53K 
90: R76         Accounts Payable (Details)                          HTML     41K 
91: R77         Accounts Payable (Parenthetical) (Details)          HTML     40K 
92: R78         Other Accrued Liabilities (Details)                 HTML     64K 
93: R79         Debt (Components of Debt) (Details)                 HTML     74K 
94: R80         Debt (Senior Secured Credit Facilities) (Details)   HTML     53K 
95: R81         Debt (Build-to-suit Lease Obligation) (Details)     HTML     36K 
96: R82         Debt (Maturities and Fair Value) (Details)          HTML     60K 
97: R83         Other Liabilities (Details)                         HTML     52K 
98: R84         Other Liabilities (Parenthetical) (Details)         HTML     33K 
99: R85         Commitments and Contingent Liabilities              HTML    124K 
                (Litigation) (Narrative) (Details)                               
100: R86         Commitments and Contingent Liabilities              HTML     47K  
                (Environmental) (Narrative) (Details)                            
101: R87         Equity (Narrative) (Details)                        HTML     63K  
102: R88         Financial Instruments (Narrative) (Details)         HTML     48K  
103: R89         Financial Instruments (Schedule of the Fair Value   HTML     48K  
                of Derivative Instruments) (Details)                             
104: R90         Long-term Employee Benefits (Schedule of Net        HTML     58K  
                Periodic Pension Income and Amounts Recognized in                
                Other Comprehensive Income (Loss) (Details)                      
105: R91         Long-term Employee Benefits (Narrative) (Details)   HTML     38K  
106: R92         Stock-based Compensation (Narrative) (Details)      HTML     89K  
107: R93         Stock-based Compensation (Stock Option Weighted     HTML     45K  
                Average Assumptions) (Details)                                   
108: R94         Segment Information (Schedule of Segment            HTML     51K  
                Information) (Details)                                           
109: R95         Segment Information - (Reconciliation of EBITDA     HTML     63K  
                from Segments to Consolidated Net Income Before                  
                Income Taxes) (Details)                                          
110: R96         Subsequent Events (Details)                         HTML    154K  
111: R97         Guarantor Condensed Consolidating Financial         HTML    112K  
                Information (Condensed Consolidating Statements of               
                Comprehensive Income) (Details)                                  
112: R98         Guarantor Condensed Consolidating Financial         HTML    176K  
                Information (Condensed Consolidating Balance                     
                Sheets) (Details)                                                
113: R99         Guarantor Condensed Consolidating Financial         HTML    114K  
                Information (Condensed Consolidating Statements of               
                Cash Flows) (Details)                                            
115: XML         IDEA XML File -- Filing Summary                      XML    224K  
114: EXCEL       IDEA Workbook of Financial Reports                  XLSX    122K  
 9: EX-101.INS  XBRL Instance -- cc-20180331                         XML   6.07M 
11: EX-101.CAL  XBRL Calculations -- cc-20180331_cal                 XML    249K 
12: EX-101.DEF  XBRL Definitions -- cc-20180331_def                  XML    877K 
13: EX-101.LAB  XBRL Labels -- cc-20180331_lab                       XML   1.47M 
14: EX-101.PRE  XBRL Presentations -- cc-20180331_pre                XML   1.34M 
10: EX-101.SCH  XBRL Schema -- cc-20180331                           XSD    254K 
116: ZIP         XBRL Zipped Folder -- 0001564590-18-010990-xbrl      Zip    265K  


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Mark P. Vergnano, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of The Chemours Company;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:

 May 4, 2018

 

 

By:

 /s/ Mark P. Vergnano

 

 

 

 Mark P. Vergnano

 

 President and Chief Executive Officer

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/4/183,  4,  8-K
For Period end:3/31/18
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Chemours Co.                      10-K       12/31/23  200:50M                                    Donnelley … Solutions/FA
 2/10/23  Chemours Co.                      10-K       12/31/22  185:39M                                    Donnelley … Solutions/FA
 2/11/22  Chemours Co.                      10-K       12/31/21  185:36M                                    ActiveDisclosure/FA
 2/12/21  Chemours Co.                      10-K       12/31/20  182:38M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-18-010990   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 9:41:29.2pm ET